40 results on '"Charlebois A"'
Search Results
2. Universal HIV Testing and Treatment With Patient-Centered Care Improves ART Uptake and Viral Suppression Among Adults Reporting Hazardous Alcohol Use in Uganda and Kenya.
3. Impact of COVID-19 Response on the HIV Epidemic in Men Who Have Sex With Men in San Francisco County: The Importance of Rapid Return to Normalcy.
4. Predicting HIV Incidence in the SEARCH Trial: A Mathematical Modeling Study.
5. Improved Viral Suppression With Streamlined Care in the SEARCH Study.
6. The Influence of Social Networks on Antiretroviral Therapy Initiation Among HIV-Infected Antiretroviral Therapy--Naive Youth in Rural Kenya and Uganda.
7. Pre-exposure Prophylaxis (PrEP) Uptake Among Older Individuals in Rural Western Kenya.
8. A Patient-Centered Multicomponent Strategy for Accelerated Linkage to Care Following Community-Wide HIV Testing in Rural Uganda and Kenya.
9. Predictors of Retention in HIV Care Among Youth (15-24) in a Universal Test-and-Treat Setting in Rural Kenya.
10. Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda.
11. Population-Based Active Tuberculosis Case Finding During Large-Scale Mobile HIV Testing Campaigns in Rural Uganda.
12. Cost and Efficiency of a Hybrid Mobile Multidisease Testing Approach With High HIV Testing Coverage in East Africa.
13. Food Insufficiency Is Associated With Lack of Sustained Viral Suppression Among HIV-Infected Pregnant and Breastfeeding Ugandan Women.
14. Isoniazid Preventive Therapy Completion in the Era of Differentiated HIV Care.
15. Examining Clinic-Based and Public Health Approaches to Ascertainment of HIV Care Status.
16. Acceptance of the Use of HIV Surveillance Data for Care Engagement: National and Local Community Perspectives.
17. Risk Factors for Preterm Birth Among HIV-Infected Pregnant Ugandan Women Randomized to Lopinavir/Ritonavir- or Efavirenz-Based Antiretroviral Therapy.
18. Virologic and Immunologic Outcomes of HIV-Infected Ugandan Children Randomized to Lopinavir/Ritonavir or Nonnucleoside Reverse Transcriptase Inhibitor Therapy.
19. Changes in Population HIV RNA Levels in Mbarara, Uganda, During Scale-up of HIV Antiretroviral Therapy Access.
20. Linkage to HIV Care in San Francisco.
21. Hair and Plasma Data Show That Lopinavir, Ritonavir, and Efavirenz All Transfer From Mother to Infant In Utero, But Only Efavirenz Transfers via Breastfeeding.
22. Resistance Patterns and Response to Entecavir Intensification Among HIV-HBV-Coinfected Adults With Persistent HBV Viremia.
23. Responding to the National HIV/AIDS Strategy-Setting the Research Agenda.
24. Psychiatric Risk Factors for HIV Disease Progression: The Role of Inconsistent Patterns of Antiretroviral Therapy Utilization.
25. Early Virologic Failure and the Development of Antiretroviral Drug Resistance Mutations in HIV-lnfected Ugandan Children.
26. Short-Term Risk of HIV Disease Progression and Death in Ugandan Children Not Eligible for Antiretroviral Therapy.
27. Lopinavir/Ritonavir Affects Pharmacokinetic Exposure of Artemether/Lumefantrine in HIV-Uninfected Healthy Volunteers.
28. A Behavioral Intervention Reduces HIV Transmission Risk by Promoting Sustained Serosorting Practices Among HIV-Infected Men Who Have Sex With Men.
29. Project Accept (HPTN 043): A Community-Based Intervention to Reduce HIV Incidence in Populations at Risk for HIV in Sub-Saharan Africa and Thailand.
30. Effects of a Behavioral Intervention on Antiretroviral Medication Adherence Among People Living With HIV The Healthy Living Project Randomized Controlled Study.
31. HIV-1 Infection in Patients Referred for Malaria Blood Smears at Government Health Clinics in Uganda.
32. Removing Barriers to Knowing HIV Status Same-Day Mobile HIV Testing in Zimbabwe.
33. Predicting HIV Transmission Risk Among HIV-Infected Men Who Have Sex With Men: Findings From the Healthy Living Project.
34. Potential Deterrent Effect of Name-Based HIV Infection Surveillance.
35. HIV Seroconversion Among the Homeless and Marginally House in San Francisco.
36. Written Clinic Procedures Enhance Delivery of HIV "Prevention With Positives" Counseling in Primary Health Care Settings.
37. Provider Assessment of Adherence to HIV Antiretroviral Therapy.
38. Unexpected Low-Level Viremia Among HIV-Infected Ugandan Adults With Untreated Active Tuberculosis.
39. HIV RNA Suppression Among HIV-lnfected Ugandan Children With Measles.
40. Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited Setting.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.